DR5 | ApexOnco - Clinical Trials news and analysis

x

“The team is super responsive to my inquiries and suggestions”

Chief Business Officer

US public biotech company

Click here for more information

Trial results

17 April 2025

RemeGen cools on DR5

A pipeline update reveals the dropping of RC248, after cMet and Claudin18.2 ADCs disappeared earlier.

Conferences Trial results

23 January 2025

ASCO-GI – Inhibrx presses ahead with DR5

Subscribe to DR5